Pharma & Healthcare
Global Veterinary Vaccine Adjuvants Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 11, 25
- ID: 301415
- Pages: 127
- Figures: 132
- Views: 1
In 2024, the global market size of Veterinary Vaccine Adjuvants was estimated to be worth US$ 345 million and is forecast to reach approximately US$ 548 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
Global 5 largest manufacturers of Veterinary Vaccine Adjuvants are SEPPIC, Croda, Vertellus, SPI Pharma and SDA BIO, which make up about 70%. Among them, SEPPIC is the leader with about 35% market share.
North America is the largest market, with a share over 30%, followed by Asia-Pacific and Europe, with the share about 30% and 22%. In terms of product type, Emulsion Adjuvants occupy the largest share of the total market, about 58%. And in terms of application, the largest application is Livestock Vaccines, followed by Companion Animals Vaccines.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine Adjuvants.
The Veterinary Vaccine Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Vaccine Adjuvants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Vaccine Adjuvants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
SEPPIC
SDA BIO
Croda
SPI Pharma
Phibro Animal Health
Vertellus
Segment by Type
Emulsion Adjuvants
Mineral Adjuvants
Others
Segment by Application
Livestock Vaccines
Companion Animals Vaccines
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Veterinary Vaccine Adjuvants in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Veterinary Vaccine Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Vaccine Adjuvants sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
Global 5 largest manufacturers of Veterinary Vaccine Adjuvants are SEPPIC, Croda, Vertellus, SPI Pharma and SDA BIO, which make up about 70%. Among them, SEPPIC is the leader with about 35% market share.
North America is the largest market, with a share over 30%, followed by Asia-Pacific and Europe, with the share about 30% and 22%. In terms of product type, Emulsion Adjuvants occupy the largest share of the total market, about 58%. And in terms of application, the largest application is Livestock Vaccines, followed by Companion Animals Vaccines.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine Adjuvants.
The Veterinary Vaccine Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Vaccine Adjuvants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Vaccine Adjuvants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
SEPPIC
SDA BIO
Croda
SPI Pharma
Phibro Animal Health
Vertellus
Segment by Type
Emulsion Adjuvants
Mineral Adjuvants
Others
Segment by Application
Livestock Vaccines
Companion Animals Vaccines
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Veterinary Vaccine Adjuvants in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Veterinary Vaccine Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Vaccine Adjuvants sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Veterinary Vaccine Adjuvants Product Introduction
1.2 Market by Type
1.2.1 Global Veterinary Vaccine Adjuvants Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Emulsion Adjuvants
1.2.3 Mineral Adjuvants
1.2.4 Others
1.3 Market by Application
1.3.1 Global Veterinary Vaccine Adjuvants Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Livestock Vaccines
1.3.3 Companion Animals Vaccines
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Veterinary Vaccine Adjuvants Market Size Estimates and Forecasts
2.1.1 Global Veterinary Vaccine Adjuvants Revenue 2020-2031
2.1.2 Global Veterinary Vaccine Adjuvants Sales 2020-2031
2.2 Veterinary Vaccine Adjuvants Market Size by Region: 2024 Versus 2031
2.3 Veterinary Vaccine Adjuvants Sales by Region (2020-2031)
2.3.1 Global Veterinary Vaccine Adjuvants Sales by Region: 2020-2025
2.3.2 Global Veterinary Vaccine Adjuvants Sales Forecast by Region (2026-2031)
2.3.3 Global Veterinary Vaccine Adjuvants Sales Market Share by Region (2020-2031)
2.4 Veterinary Vaccine Adjuvants Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Veterinary Vaccine Adjuvants Revenue by Region: 2020-2025
2.4.2 Global Veterinary Vaccine Adjuvants Revenue Forecast by Region (2026-2031)
2.4.3 Global Veterinary Vaccine Adjuvants Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Veterinary Vaccine Adjuvants Sales by Type (2020-2031)
3.1.1.1 Global Veterinary Vaccine Adjuvants Sales Volume by Type (2020-2031)
3.1.1.2 Global Veterinary Vaccine Adjuvants Sales Market Share by Type (2020-2031)
3.1.2 Global Veterinary Vaccine Adjuvants Revenue by Type (2020-2031)
3.1.2.1 Global Veterinary Vaccine Adjuvants Revenue by Type (2020-2031)
3.1.2.2 Global Veterinary Vaccine Adjuvants Revenue Market Share by Type (2020-2031)
3.1.3 Veterinary Vaccine Adjuvants Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Veterinary Vaccine Adjuvants Sales by Application (2020-2031)
3.2.1.1 Global Veterinary Vaccine Adjuvants Sales Volume by Application (2020-2031)
3.2.1.2 Global Veterinary Vaccine Adjuvants Sales Market Share by Application (2020-2031)
3.2.2 Global Veterinary Vaccine Adjuvants Revenue by Application (2020-2031)
3.2.2.1 Global Veterinary Vaccine Adjuvants Revenue by Application (2020-2031)
3.2.2.2 Global Veterinary Vaccine Adjuvants Revenue Market Share by Application (2020-2031)
3.2.3 Veterinary Vaccine Adjuvants Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Emulsion Adjuvants of Veterinary Vaccine Adjuvants Revenue Market Share by Application
3.3.2 Mineral Adjuvants of Veterinary Vaccine Adjuvants Revenue Market Share by Application
3.3.3 Others of Veterinary Vaccine Adjuvants Revenue Market Share by Application
4 Global Veterinary Vaccine Adjuvants by Manufacturers
4.1 Global Top Veterinary Vaccine Adjuvants Manufacturers by Sales (2020-2025)
4.1.1 Global Veterinary Vaccine Adjuvants Sales by Manufacturer (2020-2025)
4.1.2 Global Veterinary Vaccine Adjuvants Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Veterinary Vaccine Adjuvants Manufacturers by Revenue (2020-2025)
4.2.1 Global Veterinary Vaccine Adjuvants Revenue by Manufacturer (2020-2025)
4.2.2 Global Veterinary Vaccine Adjuvants Revenue Share by Manufacturer (2020-2025)
4.3 Global Veterinary Vaccine Adjuvants Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Veterinary Vaccine Adjuvants Manufacturers Covered: Ranking by Revenue
4.4.2 Global Veterinary Vaccine Adjuvants Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Veterinary Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Veterinary Vaccine Adjuvants Manufacturing Base Distribution, Product Type
4.5.1 Veterinary Vaccine Adjuvants Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Veterinary Vaccine Adjuvants Market
4.5.3 Manufacturers Veterinary Vaccine Adjuvants Product Type and Application
4.5.4 Emulsion Adjuvants Market Sales of Veterinary Vaccine Adjuvants by Manufacturer
4.5.5 Mineral Adjuvants Market Sales of Veterinary Vaccine Adjuvants by Manufacturer
4.5.6 Others Market Sales of Veterinary Vaccine Adjuvants by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 SEPPIC
5.1.1 SEPPIC Company Information
5.1.2 SEPPIC Description, Business Overview
5.1.3 SEPPIC Veterinary Vaccine Adjuvants Products Offered
5.1.4 SEPPIC Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
5.1.5 SEPPIC Veterinary Vaccine Adjuvants Sales by Product in 2024
5.1.6 SEPPIC Veterinary Vaccine Adjuvants Sales by Application in 2024
5.1.7 SEPPIC Veterinary Vaccine Adjuvants Sales by Geographic Area in 2024
5.1.8 SEPPIC Recent Developments
5.2 SDA BIO
5.2.1 SDA BIO Company Information
5.2.2 SDA BIO Description, Business Overview
5.2.3 SDA BIO Veterinary Vaccine Adjuvants Products Offered
5.2.4 SDA BIO Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
5.2.5 SDA BIO Veterinary Vaccine Adjuvants Sales by Product in 2024
5.2.6 SDA BIO Veterinary Vaccine Adjuvants Sales by Application in 2024
5.2.7 SDA BIO Veterinary Vaccine Adjuvants Sales by Geographic Area in 2024
5.2.8 SDA BIO Recent Developments
5.3 Croda
5.3.1 Croda Company Information
5.3.2 Croda Description, Business Overview
5.3.3 Croda Veterinary Vaccine Adjuvants Products Offered
5.3.4 Croda Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Croda Veterinary Vaccine Adjuvants Sales by Product in 2024
5.3.6 Croda Veterinary Vaccine Adjuvants Sales by Application in 2024
5.3.7 Croda Veterinary Vaccine Adjuvants Sales by Geographic Area in 2024
5.3.8 Croda Recent Developments
5.4 SPI Pharma
5.4.1 SPI Pharma Company Information
5.4.2 SPI Pharma Description, Business Overview
5.4.3 SPI Pharma Veterinary Vaccine Adjuvants Products Offered
5.4.4 SPI Pharma Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
5.4.5 SPI Pharma Veterinary Vaccine Adjuvants Sales by Product in 2024
5.4.6 SPI Pharma Veterinary Vaccine Adjuvants Sales by Application in 2024
5.4.7 SPI Pharma Veterinary Vaccine Adjuvants Sales by Geographic Area in 2024
5.4.8 SPI Pharma Recent Developments
5.5 Phibro Animal Health
5.5.1 Phibro Animal Health Company Information
5.5.2 Phibro Animal Health Description, Business Overview
5.5.3 Phibro Animal Health Veterinary Vaccine Adjuvants Products Offered
5.5.4 Phibro Animal Health Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Phibro Animal Health Veterinary Vaccine Adjuvants Sales by Product in 2024
5.5.6 Phibro Animal Health Veterinary Vaccine Adjuvants Sales by Application in 2024
5.5.7 Phibro Animal Health Veterinary Vaccine Adjuvants Sales by Geographic Area in 2024
5.5.8 Phibro Animal Health Recent Developments
5.6 Vertellus
5.6.1 Vertellus Company Information
5.6.2 Vertellus Description, Business Overview
5.6.3 Vertellus Veterinary Vaccine Adjuvants Products Offered
5.6.4 Vertellus Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Vertellus Veterinary Vaccine Adjuvants Sales by Product in 2024
5.6.6 Vertellus Veterinary Vaccine Adjuvants Sales by Application in 2024
5.6.7 Vertellus Veterinary Vaccine Adjuvants Sales by Geographic Area in 2024
5.6.8 Vertellus Recent Developments
6 North America
6.1 North America Veterinary Vaccine Adjuvants Market Size YoY Growth 2020-2031
6.2 North America Veterinary Vaccine Adjuvants Market Facts & Figures by Country
6.2.1 North America Veterinary Vaccine Adjuvants Sales by Country (2020-2031)
6.2.2 North America Veterinary Vaccine Adjuvants Revenue by Country (2020-2031)
6.3 North America Veterinary Vaccine Adjuvants Sales by Type (2020-2025)
6.4 North America Veterinary Vaccine Adjuvants Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Veterinary Vaccine Adjuvants Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Veterinary Vaccine Adjuvants Market Facts & Figures by Region
7.2.1 Asia-Pacific Veterinary Vaccine Adjuvants Sales by Region (2020-2031)
7.2.2 Asia-Pacific Veterinary Vaccine Adjuvants Revenue by Region (2020-2031)
7.3 Asia-Pacific Veterinary Vaccine Adjuvants Sales by Type (2020-2025)
7.4 Asia-Pacific Veterinary Vaccine Adjuvants Sales by Application (2020-2025)
8 Europe
8.1 Europe Veterinary Vaccine Adjuvants Market Size YoY Growth 2020-2031
8.2 Europe Veterinary Vaccine Adjuvants Market Facts & Figures by Country
8.2.1 Europe Veterinary Vaccine Adjuvants Sales by Country (2020-2031)
8.2.2 Europe Veterinary Vaccine Adjuvants Revenue by Country (2020-2031)
8.3 Europe Veterinary Vaccine Adjuvants Sales by Type (2020-2025)
8.4 Europe Veterinary Vaccine Adjuvants Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Veterinary Vaccine Adjuvants Market Size YoY Growth 2020-2031
9.2 Latin America Veterinary Vaccine Adjuvants Market Facts & Figures by Country
9.2.1 Latin America Veterinary Vaccine Adjuvants Sales by Country (2020-2031)
9.2.2 Latin America Veterinary Vaccine Adjuvants Revenue by Country (2020-2031)
9.3 Latin America Veterinary Vaccine Adjuvants Sales by Type (2020-2025)
9.4 Latin America Veterinary Vaccine Adjuvants Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Veterinary Vaccine Adjuvants Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Veterinary Vaccine Adjuvants Market Facts & Figures by Country
10.2.1 Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country (2020-2031)
10.2.2 Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country (2020-2031)
10.3 Middle East and Africa Veterinary Vaccine Adjuvants Sales by Type (2020-2025)
10.4 Middle East and Africa Veterinary Vaccine Adjuvants Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Veterinary Vaccine Adjuvants Supply Chain Analysis
11.2 Veterinary Vaccine Adjuvants Key Raw Materials and Upstream Suppliers
11.3 Veterinary Vaccine Adjuvants Clients Analysis
11.4 Veterinary Vaccine Adjuvants Sales Channel and Sales Model Analysis
11.4.1 Veterinary Vaccine Adjuvants Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Veterinary Vaccine Adjuvants Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Veterinary Vaccine Adjuvants Distributors
12 Veterinary Vaccine Adjuvants Market Dynamics
12.1 Veterinary Vaccine Adjuvants Industry Trends
12.2 Veterinary Vaccine Adjuvants Market Drivers
12.3 Veterinary Vaccine Adjuvants Market Challenges
12.4 Veterinary Vaccine Adjuvants Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Veterinary Vaccine Adjuvants Product Introduction
1.2 Market by Type
1.2.1 Global Veterinary Vaccine Adjuvants Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Emulsion Adjuvants
1.2.3 Mineral Adjuvants
1.2.4 Others
1.3 Market by Application
1.3.1 Global Veterinary Vaccine Adjuvants Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Livestock Vaccines
1.3.3 Companion Animals Vaccines
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Veterinary Vaccine Adjuvants Market Size Estimates and Forecasts
2.1.1 Global Veterinary Vaccine Adjuvants Revenue 2020-2031
2.1.2 Global Veterinary Vaccine Adjuvants Sales 2020-2031
2.2 Veterinary Vaccine Adjuvants Market Size by Region: 2024 Versus 2031
2.3 Veterinary Vaccine Adjuvants Sales by Region (2020-2031)
2.3.1 Global Veterinary Vaccine Adjuvants Sales by Region: 2020-2025
2.3.2 Global Veterinary Vaccine Adjuvants Sales Forecast by Region (2026-2031)
2.3.3 Global Veterinary Vaccine Adjuvants Sales Market Share by Region (2020-2031)
2.4 Veterinary Vaccine Adjuvants Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Veterinary Vaccine Adjuvants Revenue by Region: 2020-2025
2.4.2 Global Veterinary Vaccine Adjuvants Revenue Forecast by Region (2026-2031)
2.4.3 Global Veterinary Vaccine Adjuvants Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Veterinary Vaccine Adjuvants Sales by Type (2020-2031)
3.1.1.1 Global Veterinary Vaccine Adjuvants Sales Volume by Type (2020-2031)
3.1.1.2 Global Veterinary Vaccine Adjuvants Sales Market Share by Type (2020-2031)
3.1.2 Global Veterinary Vaccine Adjuvants Revenue by Type (2020-2031)
3.1.2.1 Global Veterinary Vaccine Adjuvants Revenue by Type (2020-2031)
3.1.2.2 Global Veterinary Vaccine Adjuvants Revenue Market Share by Type (2020-2031)
3.1.3 Veterinary Vaccine Adjuvants Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Veterinary Vaccine Adjuvants Sales by Application (2020-2031)
3.2.1.1 Global Veterinary Vaccine Adjuvants Sales Volume by Application (2020-2031)
3.2.1.2 Global Veterinary Vaccine Adjuvants Sales Market Share by Application (2020-2031)
3.2.2 Global Veterinary Vaccine Adjuvants Revenue by Application (2020-2031)
3.2.2.1 Global Veterinary Vaccine Adjuvants Revenue by Application (2020-2031)
3.2.2.2 Global Veterinary Vaccine Adjuvants Revenue Market Share by Application (2020-2031)
3.2.3 Veterinary Vaccine Adjuvants Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Emulsion Adjuvants of Veterinary Vaccine Adjuvants Revenue Market Share by Application
3.3.2 Mineral Adjuvants of Veterinary Vaccine Adjuvants Revenue Market Share by Application
3.3.3 Others of Veterinary Vaccine Adjuvants Revenue Market Share by Application
4 Global Veterinary Vaccine Adjuvants by Manufacturers
4.1 Global Top Veterinary Vaccine Adjuvants Manufacturers by Sales (2020-2025)
4.1.1 Global Veterinary Vaccine Adjuvants Sales by Manufacturer (2020-2025)
4.1.2 Global Veterinary Vaccine Adjuvants Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Veterinary Vaccine Adjuvants Manufacturers by Revenue (2020-2025)
4.2.1 Global Veterinary Vaccine Adjuvants Revenue by Manufacturer (2020-2025)
4.2.2 Global Veterinary Vaccine Adjuvants Revenue Share by Manufacturer (2020-2025)
4.3 Global Veterinary Vaccine Adjuvants Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Veterinary Vaccine Adjuvants Manufacturers Covered: Ranking by Revenue
4.4.2 Global Veterinary Vaccine Adjuvants Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Veterinary Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Veterinary Vaccine Adjuvants Manufacturing Base Distribution, Product Type
4.5.1 Veterinary Vaccine Adjuvants Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Veterinary Vaccine Adjuvants Market
4.5.3 Manufacturers Veterinary Vaccine Adjuvants Product Type and Application
4.5.4 Emulsion Adjuvants Market Sales of Veterinary Vaccine Adjuvants by Manufacturer
4.5.5 Mineral Adjuvants Market Sales of Veterinary Vaccine Adjuvants by Manufacturer
4.5.6 Others Market Sales of Veterinary Vaccine Adjuvants by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 SEPPIC
5.1.1 SEPPIC Company Information
5.1.2 SEPPIC Description, Business Overview
5.1.3 SEPPIC Veterinary Vaccine Adjuvants Products Offered
5.1.4 SEPPIC Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
5.1.5 SEPPIC Veterinary Vaccine Adjuvants Sales by Product in 2024
5.1.6 SEPPIC Veterinary Vaccine Adjuvants Sales by Application in 2024
5.1.7 SEPPIC Veterinary Vaccine Adjuvants Sales by Geographic Area in 2024
5.1.8 SEPPIC Recent Developments
5.2 SDA BIO
5.2.1 SDA BIO Company Information
5.2.2 SDA BIO Description, Business Overview
5.2.3 SDA BIO Veterinary Vaccine Adjuvants Products Offered
5.2.4 SDA BIO Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
5.2.5 SDA BIO Veterinary Vaccine Adjuvants Sales by Product in 2024
5.2.6 SDA BIO Veterinary Vaccine Adjuvants Sales by Application in 2024
5.2.7 SDA BIO Veterinary Vaccine Adjuvants Sales by Geographic Area in 2024
5.2.8 SDA BIO Recent Developments
5.3 Croda
5.3.1 Croda Company Information
5.3.2 Croda Description, Business Overview
5.3.3 Croda Veterinary Vaccine Adjuvants Products Offered
5.3.4 Croda Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Croda Veterinary Vaccine Adjuvants Sales by Product in 2024
5.3.6 Croda Veterinary Vaccine Adjuvants Sales by Application in 2024
5.3.7 Croda Veterinary Vaccine Adjuvants Sales by Geographic Area in 2024
5.3.8 Croda Recent Developments
5.4 SPI Pharma
5.4.1 SPI Pharma Company Information
5.4.2 SPI Pharma Description, Business Overview
5.4.3 SPI Pharma Veterinary Vaccine Adjuvants Products Offered
5.4.4 SPI Pharma Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
5.4.5 SPI Pharma Veterinary Vaccine Adjuvants Sales by Product in 2024
5.4.6 SPI Pharma Veterinary Vaccine Adjuvants Sales by Application in 2024
5.4.7 SPI Pharma Veterinary Vaccine Adjuvants Sales by Geographic Area in 2024
5.4.8 SPI Pharma Recent Developments
5.5 Phibro Animal Health
5.5.1 Phibro Animal Health Company Information
5.5.2 Phibro Animal Health Description, Business Overview
5.5.3 Phibro Animal Health Veterinary Vaccine Adjuvants Products Offered
5.5.4 Phibro Animal Health Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Phibro Animal Health Veterinary Vaccine Adjuvants Sales by Product in 2024
5.5.6 Phibro Animal Health Veterinary Vaccine Adjuvants Sales by Application in 2024
5.5.7 Phibro Animal Health Veterinary Vaccine Adjuvants Sales by Geographic Area in 2024
5.5.8 Phibro Animal Health Recent Developments
5.6 Vertellus
5.6.1 Vertellus Company Information
5.6.2 Vertellus Description, Business Overview
5.6.3 Vertellus Veterinary Vaccine Adjuvants Products Offered
5.6.4 Vertellus Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Vertellus Veterinary Vaccine Adjuvants Sales by Product in 2024
5.6.6 Vertellus Veterinary Vaccine Adjuvants Sales by Application in 2024
5.6.7 Vertellus Veterinary Vaccine Adjuvants Sales by Geographic Area in 2024
5.6.8 Vertellus Recent Developments
6 North America
6.1 North America Veterinary Vaccine Adjuvants Market Size YoY Growth 2020-2031
6.2 North America Veterinary Vaccine Adjuvants Market Facts & Figures by Country
6.2.1 North America Veterinary Vaccine Adjuvants Sales by Country (2020-2031)
6.2.2 North America Veterinary Vaccine Adjuvants Revenue by Country (2020-2031)
6.3 North America Veterinary Vaccine Adjuvants Sales by Type (2020-2025)
6.4 North America Veterinary Vaccine Adjuvants Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Veterinary Vaccine Adjuvants Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Veterinary Vaccine Adjuvants Market Facts & Figures by Region
7.2.1 Asia-Pacific Veterinary Vaccine Adjuvants Sales by Region (2020-2031)
7.2.2 Asia-Pacific Veterinary Vaccine Adjuvants Revenue by Region (2020-2031)
7.3 Asia-Pacific Veterinary Vaccine Adjuvants Sales by Type (2020-2025)
7.4 Asia-Pacific Veterinary Vaccine Adjuvants Sales by Application (2020-2025)
8 Europe
8.1 Europe Veterinary Vaccine Adjuvants Market Size YoY Growth 2020-2031
8.2 Europe Veterinary Vaccine Adjuvants Market Facts & Figures by Country
8.2.1 Europe Veterinary Vaccine Adjuvants Sales by Country (2020-2031)
8.2.2 Europe Veterinary Vaccine Adjuvants Revenue by Country (2020-2031)
8.3 Europe Veterinary Vaccine Adjuvants Sales by Type (2020-2025)
8.4 Europe Veterinary Vaccine Adjuvants Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Veterinary Vaccine Adjuvants Market Size YoY Growth 2020-2031
9.2 Latin America Veterinary Vaccine Adjuvants Market Facts & Figures by Country
9.2.1 Latin America Veterinary Vaccine Adjuvants Sales by Country (2020-2031)
9.2.2 Latin America Veterinary Vaccine Adjuvants Revenue by Country (2020-2031)
9.3 Latin America Veterinary Vaccine Adjuvants Sales by Type (2020-2025)
9.4 Latin America Veterinary Vaccine Adjuvants Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Veterinary Vaccine Adjuvants Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Veterinary Vaccine Adjuvants Market Facts & Figures by Country
10.2.1 Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country (2020-2031)
10.2.2 Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country (2020-2031)
10.3 Middle East and Africa Veterinary Vaccine Adjuvants Sales by Type (2020-2025)
10.4 Middle East and Africa Veterinary Vaccine Adjuvants Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Veterinary Vaccine Adjuvants Supply Chain Analysis
11.2 Veterinary Vaccine Adjuvants Key Raw Materials and Upstream Suppliers
11.3 Veterinary Vaccine Adjuvants Clients Analysis
11.4 Veterinary Vaccine Adjuvants Sales Channel and Sales Model Analysis
11.4.1 Veterinary Vaccine Adjuvants Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Veterinary Vaccine Adjuvants Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Veterinary Vaccine Adjuvants Distributors
12 Veterinary Vaccine Adjuvants Market Dynamics
12.1 Veterinary Vaccine Adjuvants Industry Trends
12.2 Veterinary Vaccine Adjuvants Market Drivers
12.3 Veterinary Vaccine Adjuvants Market Challenges
12.4 Veterinary Vaccine Adjuvants Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Veterinary Vaccine Adjuvants Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Veterinary Vaccine Adjuvants Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Veterinary Vaccine Adjuvants Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Veterinary Vaccine Adjuvants Sales by Region (2020-2025) & (K L)
Table 5. Global Veterinary Vaccine Adjuvants Sales Forecast by Region (2026-2031) & (K L)
Table 6. Global Veterinary Vaccine Adjuvants Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Veterinary Vaccine Adjuvants Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Veterinary Vaccine Adjuvants Sales Volume by Type (2020-2025) & (K L)
Table 9. Global Veterinary Vaccine Adjuvants Sales Volume by Type (2026-2031) & (K L)
Table 10. Global Veterinary Vaccine Adjuvants Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Veterinary Vaccine Adjuvants Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Veterinary Vaccine Adjuvants Sales Volume by Application (2020-2025) & (K L)
Table 13. Global Veterinary Vaccine Adjuvants Sales Volume by Application (2026-2031) & (K L)
Table 14. Global Veterinary Vaccine Adjuvants Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Veterinary Vaccine Adjuvants Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Veterinary Vaccine Adjuvants Sales by Manufacturer (2020-2025) & (K L)
Table 17. Global Veterinary Vaccine Adjuvants Sales Share by Manufacturer (2020-2025)
Table 18. Veterinary Vaccine Adjuvants Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Veterinary Vaccine Adjuvants Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Veterinary Vaccine Adjuvants Price (2020-2025) & (USD/L)
Table 21. Ranking of Global Top Veterinary Vaccine Adjuvants Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Veterinary Vaccine Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Veterinary Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine Adjuvants as of 2024)
Table 24. Veterinary Vaccine Adjuvants Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Veterinary Vaccine Adjuvants Market
Table 26. Manufacturers Veterinary Vaccine Adjuvants Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. SEPPIC Company Information
Table 29. SEPPIC Description and Business Overview
Table 30. SEPPIC Veterinary Vaccine Adjuvants Product
Table 31. SEPPIC Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
Table 32. SEPPIC Sales Proportion of Veterinary Vaccine Adjuvants by Product in 2024
Table 33. SEPPIC Sales Proportion of Veterinary Vaccine Adjuvants by Application in 2024
Table 34. SEPPIC Sales Proportion of Veterinary Vaccine Adjuvants by Geographic Area in 2024
Table 35. SEPPIC Recent Developments
Table 36. SDA BIO Company Information
Table 37. SDA BIO Description and Business Overview
Table 38. SDA BIO Veterinary Vaccine Adjuvants Product
Table 39. SDA BIO Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
Table 40. SDA BIO Sales Proportion of Veterinary Vaccine Adjuvants by Product in 2024
Table 41. SDA BIO Sales Proportion of Veterinary Vaccine Adjuvants by Application in 2024
Table 42. SDA BIO Sales Proportion of Veterinary Vaccine Adjuvants by Geographic Area in 2024
Table 43. SDA BIO Recent Developments
Table 44. Croda Company Information
Table 45. Croda Description and Business Overview
Table 46. Croda Veterinary Vaccine Adjuvants Product
Table 47. Croda Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
Table 48. Croda Sales Proportion of Veterinary Vaccine Adjuvants by Product in 2024
Table 49. Croda Sales Proportion of Veterinary Vaccine Adjuvants by Application in 2024
Table 50. Croda Sales Proportion of Veterinary Vaccine Adjuvants by Geographic Area in 2024
Table 51. Croda Recent Developments
Table 52. SPI Pharma Company Information
Table 53. SPI Pharma Description and Business Overview
Table 54. SPI Pharma Veterinary Vaccine Adjuvants Product
Table 55. SPI Pharma Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
Table 56. SPI Pharma Sales Proportion of Veterinary Vaccine Adjuvants by Product in 2024
Table 57. SPI Pharma Sales Proportion of Veterinary Vaccine Adjuvants by Application in 2024
Table 58. SPI Pharma Sales Proportion of Veterinary Vaccine Adjuvants by Geographic Area in 2024
Table 59. SPI Pharma Recent Developments
Table 60. Phibro Animal Health Company Information
Table 61. Phibro Animal Health Description and Business Overview
Table 62. Phibro Animal Health Veterinary Vaccine Adjuvants Product
Table 63. Phibro Animal Health Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
Table 64. Phibro Animal Health Sales Proportion of Veterinary Vaccine Adjuvants by Product in 2024
Table 65. Phibro Animal Health Sales Proportion of Veterinary Vaccine Adjuvants by Application in 2024
Table 66. Phibro Animal Health Sales Proportion of Veterinary Vaccine Adjuvants by Geographic Area in 2024
Table 67. Phibro Animal Health Recent Developments
Table 68. Vertellus Company Information
Table 69. Vertellus Description and Business Overview
Table 70. Vertellus Veterinary Vaccine Adjuvants Product
Table 71. Vertellus Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
Table 72. Vertellus Sales Proportion of Veterinary Vaccine Adjuvants by Product in 2024
Table 73. Vertellus Sales Proportion of Veterinary Vaccine Adjuvants by Application in 2024
Table 74. Vertellus Sales Proportion of Veterinary Vaccine Adjuvants by Geographic Area in 2024
Table 75. Vertellus Recent Developments
Table 76. North America Veterinary Vaccine Adjuvants Sales by Country (2020-2025) & (K L)
Table 77. North America Veterinary Vaccine Adjuvants Sales by Country (2026-2031) & (K L)
Table 78. North America Veterinary Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
Table 79. North America Veterinary Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
Table 80. North America Veterinary Vaccine Adjuvants Sales by Type (2020-2025) & (K L)
Table 81. North America Veterinary Vaccine Adjuvants Sales by Application (2020-2025) & (K L)
Table 82. Asia-Pacific Veterinary Vaccine Adjuvants Sales by Region (2020-2025) & (K L)
Table 83. Asia-Pacific Veterinary Vaccine Adjuvants Sales by Region (2026-2031) & (K L)
Table 84. Asia-Pacific Veterinary Vaccine Adjuvants Revenue by Region (2020-2025) & (US$ Million)
Table 85. Asia-Pacific Veterinary Vaccine Adjuvants Revenue by Region (2026-2031) & (US$ Million)
Table 86. Asia-Pacific Veterinary Vaccine Adjuvants Sales by Type (2020-2025) & (K L)
Table 87. Asia-Pacific Veterinary Vaccine Adjuvants Sales by Application (2020-2025) & (K L)
Table 88. Europe Veterinary Vaccine Adjuvants Sales by Country (2020-2025) & (K L)
Table 89. Europe Veterinary Vaccine Adjuvants Sales by Country (2026-2031) & (K L)
Table 90. Europe Veterinary Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
Table 91. Europe Veterinary Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
Table 92. Europe Veterinary Vaccine Adjuvants Sales by Type (2020-2025) & (K L)
Table 93. Europe Veterinary Vaccine Adjuvants Sales by Application (2020-2025) & (K L)
Table 94. Latin America Veterinary Vaccine Adjuvants Sales by Country (2020-2025) & (K L)
Table 95. Latin America Veterinary Vaccine Adjuvants Sales by Country (2026-2031) & (K L)
Table 96. Latin America Veterinary Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
Table 97. Latin America Veterinary Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
Table 98. Latin America Veterinary Vaccine Adjuvants Sales by Type (2020-2025) & (K L)
Table 99. Latin America Veterinary Vaccine Adjuvants Sales by Application (2020-2025) & (K L)
Table 100. Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country (2020-2025) & (K L)
Table 101. Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country (2026-2031) & (K L)
Table 102. Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
Table 103. Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
Table 104. Middle East and Africa Veterinary Vaccine Adjuvants Sales by Type (2020-2025) & (K L)
Table 105. Middle East and Africa Veterinary Vaccine Adjuvants Sales by Application (2020-2025) & (K L)
Table 106. Veterinary Vaccine Adjuvants Key Raw Materials, Industry Status and Trend
Table 107. Veterinary Vaccine Adjuvants Key Raw Materials and Upstream Suppliers
Table 108. Veterinary Vaccine Adjuvants Clients Status and Trend
Table 109. Veterinary Vaccine Adjuvants Typical Clients
Table 110. Veterinary Vaccine Adjuvants Distributors
Table 111. Veterinary Vaccine Adjuvants Market Trends
Table 112. Veterinary Vaccine Adjuvants Market Drivers
Table 113. Veterinary Vaccine Adjuvants Market Challenges
Table 114. Veterinary Vaccine Adjuvants Market Restraints
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Veterinary Vaccine Adjuvants Product Picture
Figure 2. Global Veterinary Vaccine Adjuvants Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Veterinary Vaccine Adjuvants Sales Market Share by Type in 2024 & 2031
Figure 4. Emulsion Adjuvants Product Picture
Figure 5. Mineral Adjuvants Product Picture
Figure 6. Others Product Picture
Figure 7. Global Veterinary Vaccine Adjuvants Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Veterinary Vaccine Adjuvants Sales Market Share by Application in 2024 & 2031
Figure 9. Livestock Vaccines
Figure 10. Companion Animals Vaccines
Figure 11. Veterinary Vaccine Adjuvants Report Years Considered
Figure 12. Global Veterinary Vaccine Adjuvants Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Veterinary Vaccine Adjuvants Market Size 2020-2031 (US$ Million)
Figure 14. Global Veterinary Vaccine Adjuvants Sales 2020-2031 (K L)
Figure 15. Global Veterinary Vaccine Adjuvants Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Veterinary Vaccine Adjuvants Revenue Market Share by Region (2020-2031)
Figure 17. Global Veterinary Vaccine Adjuvants Sales Market Share Forecast by Type (2020-2031)
Figure 18. Global Veterinary Vaccine Adjuvants Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Veterinary Vaccine Adjuvants Average Selling Price (ASP) by Type (2020-2025) & (USD/L)
Figure 20. Global Veterinary Vaccine Adjuvants Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Veterinary Vaccine Adjuvants Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Veterinary Vaccine Adjuvants Average Selling Price (ASP) by Application (2020-2025) & (USD/L)
Figure 23. Emulsion Adjuvants of Veterinary Vaccine Adjuvants Revenue Market Share by Application, 2024 VS 2031
Figure 24. Mineral Adjuvants of Veterinary Vaccine Adjuvants Revenue Market Share by Application, 2024 VS 2031
Figure 25. Others of Veterinary Vaccine Adjuvants Revenue Market Share by Application, 2024 VS 2031
Figure 26. Global Veterinary Vaccine Adjuvants Sales Share by Manufacturer in 2024
Figure 27. Veterinary Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Emulsion Adjuvants Market Sales Proportion by Manufacturer in 2024
Figure 29. Mineral Adjuvants Market Sales Proportion by Manufacturer in 2024
Figure 30. Others Market Sales Proportion by Manufacturer in 2024
Figure 31. North America Veterinary Vaccine Adjuvants Revenue 2020-2031 (US$ Million)
Figure 32. North America Veterinary Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Figure 33. North America Veterinary Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Figure 34. Asia-Pacific Veterinary Vaccine Adjuvants Revenue 2020-2031 (US$ Million)
Figure 35. Asia-Pacific Veterinary Vaccine Adjuvants Sales Market Share by Region (2020-2031)
Figure 36. Asia-Pacific Veterinary Vaccine Adjuvants Revenue Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Veterinary Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Figure 38. Asia-Pacific Veterinary Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Figure 39. Europe Veterinary Vaccine Adjuvants Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Europe Veterinary Vaccine Adjuvants Sales Market Share by Country (2020-2031)
Figure 41. Europe Veterinary Vaccine Adjuvants Revenue Market Share by Country (2020-2031)
Figure 42. Europe Veterinary Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Figure 43. Europe Veterinary Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Figure 44. Latin America Veterinary Vaccine Adjuvants Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Latin America Veterinary Vaccine Adjuvants Sales Market Share by Country (2020-2031)
Figure 46. Latin America Veterinary Vaccine Adjuvants Revenue Market Share by Country (2020-2025)
Figure 47. Latin America Veterinary Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Figure 48. Latin America Veterinary Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Figure 49. Middle East and Africa Veterinary Vaccine Adjuvants Revenue Growth Rate 2020-2031 (US$ Million)
Figure 50. Middle East and Africa Veterinary Vaccine Adjuvants Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Veterinary Vaccine Adjuvants Revenue Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Veterinary Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Figure 53. Middle East and Africa Veterinary Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Figure 54. Veterinary Vaccine Adjuvants Supply Chain (Upstream and Downstream Market)
Figure 55. Global Production Market Share of Veterinary Vaccine Adjuvants Raw Materials by Region in 2024
Figure 56. Veterinary Vaccine Adjuvants Distribution Channels
Figure 57. Global Veterinary Vaccine Adjuvants Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 58. Global Veterinary Vaccine Adjuvants Percentage 2020-2031: Online Sales VS Offline Sales
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Veterinary Vaccine Adjuvants Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Veterinary Vaccine Adjuvants Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Veterinary Vaccine Adjuvants Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Veterinary Vaccine Adjuvants Sales by Region (2020-2025) & (K L)
Table 5. Global Veterinary Vaccine Adjuvants Sales Forecast by Region (2026-2031) & (K L)
Table 6. Global Veterinary Vaccine Adjuvants Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Veterinary Vaccine Adjuvants Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Veterinary Vaccine Adjuvants Sales Volume by Type (2020-2025) & (K L)
Table 9. Global Veterinary Vaccine Adjuvants Sales Volume by Type (2026-2031) & (K L)
Table 10. Global Veterinary Vaccine Adjuvants Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Veterinary Vaccine Adjuvants Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Veterinary Vaccine Adjuvants Sales Volume by Application (2020-2025) & (K L)
Table 13. Global Veterinary Vaccine Adjuvants Sales Volume by Application (2026-2031) & (K L)
Table 14. Global Veterinary Vaccine Adjuvants Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Veterinary Vaccine Adjuvants Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Veterinary Vaccine Adjuvants Sales by Manufacturer (2020-2025) & (K L)
Table 17. Global Veterinary Vaccine Adjuvants Sales Share by Manufacturer (2020-2025)
Table 18. Veterinary Vaccine Adjuvants Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Veterinary Vaccine Adjuvants Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Veterinary Vaccine Adjuvants Price (2020-2025) & (USD/L)
Table 21. Ranking of Global Top Veterinary Vaccine Adjuvants Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Veterinary Vaccine Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Veterinary Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine Adjuvants as of 2024)
Table 24. Veterinary Vaccine Adjuvants Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Veterinary Vaccine Adjuvants Market
Table 26. Manufacturers Veterinary Vaccine Adjuvants Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. SEPPIC Company Information
Table 29. SEPPIC Description and Business Overview
Table 30. SEPPIC Veterinary Vaccine Adjuvants Product
Table 31. SEPPIC Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
Table 32. SEPPIC Sales Proportion of Veterinary Vaccine Adjuvants by Product in 2024
Table 33. SEPPIC Sales Proportion of Veterinary Vaccine Adjuvants by Application in 2024
Table 34. SEPPIC Sales Proportion of Veterinary Vaccine Adjuvants by Geographic Area in 2024
Table 35. SEPPIC Recent Developments
Table 36. SDA BIO Company Information
Table 37. SDA BIO Description and Business Overview
Table 38. SDA BIO Veterinary Vaccine Adjuvants Product
Table 39. SDA BIO Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
Table 40. SDA BIO Sales Proportion of Veterinary Vaccine Adjuvants by Product in 2024
Table 41. SDA BIO Sales Proportion of Veterinary Vaccine Adjuvants by Application in 2024
Table 42. SDA BIO Sales Proportion of Veterinary Vaccine Adjuvants by Geographic Area in 2024
Table 43. SDA BIO Recent Developments
Table 44. Croda Company Information
Table 45. Croda Description and Business Overview
Table 46. Croda Veterinary Vaccine Adjuvants Product
Table 47. Croda Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
Table 48. Croda Sales Proportion of Veterinary Vaccine Adjuvants by Product in 2024
Table 49. Croda Sales Proportion of Veterinary Vaccine Adjuvants by Application in 2024
Table 50. Croda Sales Proportion of Veterinary Vaccine Adjuvants by Geographic Area in 2024
Table 51. Croda Recent Developments
Table 52. SPI Pharma Company Information
Table 53. SPI Pharma Description and Business Overview
Table 54. SPI Pharma Veterinary Vaccine Adjuvants Product
Table 55. SPI Pharma Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
Table 56. SPI Pharma Sales Proportion of Veterinary Vaccine Adjuvants by Product in 2024
Table 57. SPI Pharma Sales Proportion of Veterinary Vaccine Adjuvants by Application in 2024
Table 58. SPI Pharma Sales Proportion of Veterinary Vaccine Adjuvants by Geographic Area in 2024
Table 59. SPI Pharma Recent Developments
Table 60. Phibro Animal Health Company Information
Table 61. Phibro Animal Health Description and Business Overview
Table 62. Phibro Animal Health Veterinary Vaccine Adjuvants Product
Table 63. Phibro Animal Health Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
Table 64. Phibro Animal Health Sales Proportion of Veterinary Vaccine Adjuvants by Product in 2024
Table 65. Phibro Animal Health Sales Proportion of Veterinary Vaccine Adjuvants by Application in 2024
Table 66. Phibro Animal Health Sales Proportion of Veterinary Vaccine Adjuvants by Geographic Area in 2024
Table 67. Phibro Animal Health Recent Developments
Table 68. Vertellus Company Information
Table 69. Vertellus Description and Business Overview
Table 70. Vertellus Veterinary Vaccine Adjuvants Product
Table 71. Vertellus Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
Table 72. Vertellus Sales Proportion of Veterinary Vaccine Adjuvants by Product in 2024
Table 73. Vertellus Sales Proportion of Veterinary Vaccine Adjuvants by Application in 2024
Table 74. Vertellus Sales Proportion of Veterinary Vaccine Adjuvants by Geographic Area in 2024
Table 75. Vertellus Recent Developments
Table 76. North America Veterinary Vaccine Adjuvants Sales by Country (2020-2025) & (K L)
Table 77. North America Veterinary Vaccine Adjuvants Sales by Country (2026-2031) & (K L)
Table 78. North America Veterinary Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
Table 79. North America Veterinary Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
Table 80. North America Veterinary Vaccine Adjuvants Sales by Type (2020-2025) & (K L)
Table 81. North America Veterinary Vaccine Adjuvants Sales by Application (2020-2025) & (K L)
Table 82. Asia-Pacific Veterinary Vaccine Adjuvants Sales by Region (2020-2025) & (K L)
Table 83. Asia-Pacific Veterinary Vaccine Adjuvants Sales by Region (2026-2031) & (K L)
Table 84. Asia-Pacific Veterinary Vaccine Adjuvants Revenue by Region (2020-2025) & (US$ Million)
Table 85. Asia-Pacific Veterinary Vaccine Adjuvants Revenue by Region (2026-2031) & (US$ Million)
Table 86. Asia-Pacific Veterinary Vaccine Adjuvants Sales by Type (2020-2025) & (K L)
Table 87. Asia-Pacific Veterinary Vaccine Adjuvants Sales by Application (2020-2025) & (K L)
Table 88. Europe Veterinary Vaccine Adjuvants Sales by Country (2020-2025) & (K L)
Table 89. Europe Veterinary Vaccine Adjuvants Sales by Country (2026-2031) & (K L)
Table 90. Europe Veterinary Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
Table 91. Europe Veterinary Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
Table 92. Europe Veterinary Vaccine Adjuvants Sales by Type (2020-2025) & (K L)
Table 93. Europe Veterinary Vaccine Adjuvants Sales by Application (2020-2025) & (K L)
Table 94. Latin America Veterinary Vaccine Adjuvants Sales by Country (2020-2025) & (K L)
Table 95. Latin America Veterinary Vaccine Adjuvants Sales by Country (2026-2031) & (K L)
Table 96. Latin America Veterinary Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
Table 97. Latin America Veterinary Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
Table 98. Latin America Veterinary Vaccine Adjuvants Sales by Type (2020-2025) & (K L)
Table 99. Latin America Veterinary Vaccine Adjuvants Sales by Application (2020-2025) & (K L)
Table 100. Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country (2020-2025) & (K L)
Table 101. Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country (2026-2031) & (K L)
Table 102. Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
Table 103. Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
Table 104. Middle East and Africa Veterinary Vaccine Adjuvants Sales by Type (2020-2025) & (K L)
Table 105. Middle East and Africa Veterinary Vaccine Adjuvants Sales by Application (2020-2025) & (K L)
Table 106. Veterinary Vaccine Adjuvants Key Raw Materials, Industry Status and Trend
Table 107. Veterinary Vaccine Adjuvants Key Raw Materials and Upstream Suppliers
Table 108. Veterinary Vaccine Adjuvants Clients Status and Trend
Table 109. Veterinary Vaccine Adjuvants Typical Clients
Table 110. Veterinary Vaccine Adjuvants Distributors
Table 111. Veterinary Vaccine Adjuvants Market Trends
Table 112. Veterinary Vaccine Adjuvants Market Drivers
Table 113. Veterinary Vaccine Adjuvants Market Challenges
Table 114. Veterinary Vaccine Adjuvants Market Restraints
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Veterinary Vaccine Adjuvants Product Picture
Figure 2. Global Veterinary Vaccine Adjuvants Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Veterinary Vaccine Adjuvants Sales Market Share by Type in 2024 & 2031
Figure 4. Emulsion Adjuvants Product Picture
Figure 5. Mineral Adjuvants Product Picture
Figure 6. Others Product Picture
Figure 7. Global Veterinary Vaccine Adjuvants Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Veterinary Vaccine Adjuvants Sales Market Share by Application in 2024 & 2031
Figure 9. Livestock Vaccines
Figure 10. Companion Animals Vaccines
Figure 11. Veterinary Vaccine Adjuvants Report Years Considered
Figure 12. Global Veterinary Vaccine Adjuvants Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Veterinary Vaccine Adjuvants Market Size 2020-2031 (US$ Million)
Figure 14. Global Veterinary Vaccine Adjuvants Sales 2020-2031 (K L)
Figure 15. Global Veterinary Vaccine Adjuvants Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Veterinary Vaccine Adjuvants Revenue Market Share by Region (2020-2031)
Figure 17. Global Veterinary Vaccine Adjuvants Sales Market Share Forecast by Type (2020-2031)
Figure 18. Global Veterinary Vaccine Adjuvants Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Veterinary Vaccine Adjuvants Average Selling Price (ASP) by Type (2020-2025) & (USD/L)
Figure 20. Global Veterinary Vaccine Adjuvants Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Veterinary Vaccine Adjuvants Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Veterinary Vaccine Adjuvants Average Selling Price (ASP) by Application (2020-2025) & (USD/L)
Figure 23. Emulsion Adjuvants of Veterinary Vaccine Adjuvants Revenue Market Share by Application, 2024 VS 2031
Figure 24. Mineral Adjuvants of Veterinary Vaccine Adjuvants Revenue Market Share by Application, 2024 VS 2031
Figure 25. Others of Veterinary Vaccine Adjuvants Revenue Market Share by Application, 2024 VS 2031
Figure 26. Global Veterinary Vaccine Adjuvants Sales Share by Manufacturer in 2024
Figure 27. Veterinary Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Emulsion Adjuvants Market Sales Proportion by Manufacturer in 2024
Figure 29. Mineral Adjuvants Market Sales Proportion by Manufacturer in 2024
Figure 30. Others Market Sales Proportion by Manufacturer in 2024
Figure 31. North America Veterinary Vaccine Adjuvants Revenue 2020-2031 (US$ Million)
Figure 32. North America Veterinary Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Figure 33. North America Veterinary Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Figure 34. Asia-Pacific Veterinary Vaccine Adjuvants Revenue 2020-2031 (US$ Million)
Figure 35. Asia-Pacific Veterinary Vaccine Adjuvants Sales Market Share by Region (2020-2031)
Figure 36. Asia-Pacific Veterinary Vaccine Adjuvants Revenue Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Veterinary Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Figure 38. Asia-Pacific Veterinary Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Figure 39. Europe Veterinary Vaccine Adjuvants Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Europe Veterinary Vaccine Adjuvants Sales Market Share by Country (2020-2031)
Figure 41. Europe Veterinary Vaccine Adjuvants Revenue Market Share by Country (2020-2031)
Figure 42. Europe Veterinary Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Figure 43. Europe Veterinary Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Figure 44. Latin America Veterinary Vaccine Adjuvants Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Latin America Veterinary Vaccine Adjuvants Sales Market Share by Country (2020-2031)
Figure 46. Latin America Veterinary Vaccine Adjuvants Revenue Market Share by Country (2020-2025)
Figure 47. Latin America Veterinary Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Figure 48. Latin America Veterinary Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Figure 49. Middle East and Africa Veterinary Vaccine Adjuvants Revenue Growth Rate 2020-2031 (US$ Million)
Figure 50. Middle East and Africa Veterinary Vaccine Adjuvants Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Veterinary Vaccine Adjuvants Revenue Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Veterinary Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Figure 53. Middle East and Africa Veterinary Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Figure 54. Veterinary Vaccine Adjuvants Supply Chain (Upstream and Downstream Market)
Figure 55. Global Production Market Share of Veterinary Vaccine Adjuvants Raw Materials by Region in 2024
Figure 56. Veterinary Vaccine Adjuvants Distribution Channels
Figure 57. Global Veterinary Vaccine Adjuvants Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 58. Global Veterinary Vaccine Adjuvants Percentage 2020-2031: Online Sales VS Offline Sales
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Medical Waste Fluid Solidifier Market Research Report 2025
Jun 12, 25
Global Metalized Bubble Material Market Research Report 2025
Jun 12, 25
Global 70% Isopropyl Rubbing Alcohol Market Research Report 2025
Jun 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232